Infection, Antibiotics, and Patient Outcomes in the Intensive Care Unit
JAMA
.
2020 Apr 21;323(15):1451-1452.
doi: 10.1001/jama.2020.2241.
Authors
Mo Yin
1
2
3
4
,
Paul Anantharajah Tambyah
1
2
,
Eli N Perencevich
5
6
Affiliations
1
Division of Infectious Disease, University Medicine Cluster, National University Hospital, Singapore.
2
Department of Medicine, National University of Singapore, Singapore.
3
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Salaya, Thailand.
4
Nuffield Department of Medicine, University of Oxford, Oxford, England.
5
Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City.
6
Center for Access and Delivery Research and Evaluation, Iowa City VA Health Care System, Iowa City, Iowa.
PMID:
32207775
DOI:
10.1001/jama.2020.2241
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Bacterial Agents*
Cross Infection*
Humans
Intensive Care Units
Prevalence
Substances
Anti-Bacterial Agents